5
Participants
Start Date
August 31, 2015
Primary Completion Date
September 30, 2019
Study Completion Date
September 30, 2019
Alpha-1 Antitrypsin
"Subjects will receive their islets treated with Aralast NP during islet isolation process.~Subjects will receive Aralast NP at a dose of 120 mg/kg (at an infusion rate of 0.2 mL/kg/min or less), dependent on patient tolerance, based on Day -1 admission weight and dose rounded to the nearest 20 mg) at the following time points:~* Pre-transplant Day -1~* Post-transplant Day 3~* Post-transplant Day 7~* Post-transplant Day 14"
University of Alberta, Edmonton
Collaborators (1)
Shire
INDUSTRY
University of Alberta
OTHER